What Is PGT and PGD? Understanding the Clinical Difference
Preimplantation Genetic Testing (PGT) is an umbrella term for genetic analysis performed on embryos created through IVF before they are transferred to the uterus. Within this umbrella, three distinct subtypes serve different clinical purposes.
PGT-A (formerly PGS) screens embryos for aneuploidy — an abnormal number of chromosomes. This is the most commonly requested test in Maharashtra IVF cycles, particularly for women over 35 or couples with unexplained recurrent implantation failure. PGT-M (formerly PGD) tests for specific single-gene disorders such as thalassaemia, sickle cell disease, spinal muscular atrophy, or cystic fibrosis. PGT-SR assesses structural chromosomal rearrangements such as translocations, which are a known cause of recurrent pregnancy loss.
The biopsy itself is a microsurgical procedure performed in the embryology laboratory: a trained embryologist removes one to five cells from the trophectoderm layer of a Day 5 or Day 6 blastocyst. These cells are sent to a NABL-accredited genetics laboratory — facilities in Mumbai and Pune are most commonly used for Maharashtra patients — where next-generation sequencing (NGS) or array comparative genomic hybridisation (aCGH) produces a detailed chromosomal map. Only embryos confirmed as euploid (chromosomally normal) and free of the targeted single-gene disorder are selected for transfer, substantially reducing the risk of failed implantation and miscarriage.
Who in Maharashtra Should Consider Genetic Testing Before IVF?
Genetic testing is not a universal requirement for every IVF cycle, but clinical guidelines identify several high-priority groups for whom PGT or PGD is strongly advisable. The HomeIVF Medical Board recommends a thorough fertility consultation before deciding whether testing is warranted for your specific situation.
Women aged 37 and above undergoing IVF in Maharashtra account for the largest proportion of PGT-A referrals, because chromosomal errors in embryos rise sharply with maternal age — from roughly 30% at age 35 to over 60% by age 42. Couples who have experienced two or more consecutive miscarriages, particularly those living in Thane, Nashik, or Aurangabad where specialist genetic counselling was previously hard to access, now benefit from HomeIVF's teleconsultation model for early triage.
Carriers of known hereditary conditions are another critical group. Maharashtra has one of India's highest carrier rates for beta-thalassaemia, a fact well documented in communities across Pune and Nagpur. Couples where both partners carry the thalassaemia gene have a 25% chance of an affected child in every pregnancy; PGT-M effectively eliminates this risk at the embryo stage. Similarly, families with a history of Huntington's disease, BRCA mutations, or spinal muscular atrophy should discuss PGT-M with a genetic counsellor before proceeding with IVF.
Talk to a Fertility Expert — Free
Book a free consultation. Our specialists will guide you on the right path, including Home IVF.
or chat on WhatsApp →Recognising the Signs That Warrant a Genetic Workup
Unlike many fertility conditions, chromosomal or single-gene disorders rarely produce obvious physical symptoms in the parent — they are often only discovered after a pregnancy loss, the birth of an affected child, or incidental carrier screening. Knowing which clinical patterns should prompt a referral for genetic evaluation can save Maharashtra couples months of unexplained treatment failure.
Recurrent implantation failure — defined as two or more failed embryo transfers using good-quality embryos — is one of the clearest indicators. Many couples in Mumbai and Pune reach this point after three or four IVF attempts without any structural or hormonal explanation, only to discover via PGT-A that the majority of their embryos were aneuploid.
A family history of genetic disease is an equally important trigger. If a first-degree relative has been diagnosed with a dominant hereditary disorder, or if both partners have tested positive as carriers of a recessive condition through routine blood-based carrier screening, PGT-M planning should begin before egg retrieval — not after. Unexplained stillbirth, a child born with developmental disabilities of unknown cause, or male-factor infertility linked to chromosomal microdeletions (detectable on a karyotype or FISH test) are additional red flags. HomeIVF's home-visit model allows a phlebotomist to collect samples for carrier screening without patients needing to travel to a clinic.
The Step-by-Step PGT Process: From Consultation to Embryo Transfer
Understanding the exact clinical workflow removes much of the anxiety surrounding genetic testing. The HomeIVF Medical Board has mapped a standardised pathway for Maharashtra patients that integrates home-based monitoring with partner IVF laboratories in Mumbai, Pune, and Nagpur.
Step 1 — Genetic Counselling: A certified genetic counsellor (accessed via HomeIVF's teleconsultation platform) reviews personal and family medical history, orders relevant carrier screening bloodwork, and advises whether PGT-A, PGT-M, or PGT-SR is indicated.
Step 2 — Ovarian Stimulation and Egg Retrieval: Standard IVF stimulation protocols apply. HomeIVF nurses visit the patient's home in cities across Maharashtra to administer injections and collect blood samples for hormone monitoring, reducing clinic visits to the essential minimum.
Step 3 — Embryo Culture and Biopsy: Fertilised eggs are cultured to the blastocyst stage (Day 5-6) at the partner laboratory. A skilled embryologist biopsies the trophectoderm cells under a high-powered microscope.
Step 4 — Genetic Analysis: Biopsied cells are sent to a NABL-accredited genetics lab. NGS analysis returns results within 10-14 working days for most Maharashtra-based samples.
Step 5 — Embryo Selection and Transfer: Only euploid, unaffected embryos are ranked for transfer. A frozen embryo transfer (FET) cycle is then planned, often in the subsequent menstrual cycle.
Treatment Options and HomeIVF's Role in Your Maharashtra PGT Cycle
HomeIVF does not replace the embryology laboratory or surgical retrieval — it delivers senior-specialist care at home at every stage that can safely occur outside a clinical setting. This hybrid model is particularly valuable for Maharashtra patients who live in cities like Nashik, Kolhapur, or Solapur, where access to a dedicated IVF centre with an in-house genetics programme has historically been limited.
Through HomeIVF, patients receive at-home hormone injections administered by trained fertility nurses, home-visit blood draws for oestradiol, LH, and progesterone monitoring during stimulation, and teleconsultation with reproductive medicine specialists for result interpretation and medication adjustments. When retrieval and biopsy are required, HomeIVF coordinates the patient's transfer to an empanelled partner clinic in the nearest major city — typically Mumbai, Pune, or Nagpur.
Post-biopsy genetic reports are reviewed jointly by the HomeIVF Medical Board and the treating specialist, and a detailed embryo selection recommendation is communicated to the patient via a one-on-one video consultation. The frozen embryo transfer preparation — endometrial monitoring, progesterone supplementation, and trigger timing — can again be managed largely at home through HomeIVF's nurse and teleconsultation network. IVF packages with PGT integration start from ₹1.5 lakh, with genetic testing costs added transparently based on the number of embryos biopsied.
Cost, Timelines, and What to Expect in Maharashtra
One of the most common questions the HomeIVF Medical Board receives from Maharashtra patients is how much a PGT cycle costs and how long the entire process takes. While exact figures depend on the specific test type, number of embryos, and partner laboratory, realistic expectations help with planning.
A complete IVF-plus-PGT-A cycle in Maharashtra typically spans 8-12 weeks from the start of stimulation to embryo transfer — accounting for 10-14 days of stimulation, 5-6 days of blastocyst culture, 10-14 working days for NGS analysis, and 3-4 weeks for frozen embryo transfer preparation. If the first retrieval cycle yields fewer than two blastocysts suitable for biopsy, a second stimulation cycle may be recommended before transfer, extending the timeline.
In terms of financial planning, genetic analysis pricing in India is directly linked to the number of embryos tested and the complexity of the panel — PGT-M for a single-gene disorder costs more than standard PGT-A. Maharashtra patients accessing HomeIVF benefit from transparent cost breakdowns at the consultation stage, with no hidden laboratory surcharges. Couples in Pune and Mumbai have also found that HomeIVF's home-monitoring model reduces out-of-pocket transport and leave-from-work costs significantly compared to daily clinic visits during stimulation.
Local Barriers to Genetic Testing in Maharashtra — and How HomeIVF Removes Them
Despite Maharashtra being one of India's most medically advanced states, significant barriers to PGT access persist outside Mumbai and Pune. Couples in Nagpur, Amravati, Jalgaon, and Aurangabad frequently report travelling four to six hours each way for monitoring appointments during IVF stimulation — a physical and financial burden that leads many to abandon treatment before completing a full cycle.
A second barrier is lack of genetic counselling. Many fertility clinics in tier-2 Maharashtra cities offer IVF but do not have a certified genetic counsellor on staff, meaning patients either skip PGT entirely or receive inadequate pre-test education about what abnormal results actually mean clinically.
HomeIVF directly addresses both barriers. Its home-visit network currently covers over 50 cities and towns across Maharashtra, meaning stimulation monitoring no longer requires daily travel. Genetic counselling is delivered via teleconsultation, making it equally accessible to a patient in Nashik as to one in South Mumbai. Partner NABL-accredited laboratories in Mumbai and Pune handle biopsy and analysis, with HomeIVF coordinating sample logistics. The result is a clinically rigorous PGT pathway that previously existed only for patients with proximity to a major urban fertility centre.
Success Archetypes: The Maharashtra Patient Profiles HomeIVF Supports
The HomeIVF Medical Board has identified several recurring patient profiles across Maharashtra for whom PGT integration has meaningfully changed treatment outcomes — not invented individuals, but composite clinical archetypes drawn from real referral patterns.
The first archetype is the couple in their late 30s in Thane who have completed two IVF cycles with good-quality Day 3 embryos but experienced failed implantation each time. Adding PGT-A to their third cycle revealed that 60% of their blastocysts were aneuploid; transferring the single euploid embryo identified resulted in a sustained pregnancy.
The second archetype is a Pune-based couple, both carriers of the beta-thalassaemia trait, who had declined IVF for two years fearing the complexity and cost of PGT-M. HomeIVF's teleconsultation model connected them with a genetic counsellor and a specialist who co-designed a PGT-M protocol. Three unaffected embryos were identified for future transfer — restoring genuine reproductive choice without the ethical burden of prenatal diagnosis and termination.
The third archetype is a single woman in Mumbai pursuing IVF with donor sperm who opted for PGT-A to maximise the probability of success per transfer, given the emotional and financial cost of each attempt. IVF success rates in India typically range from 40-55% per cycle depending on age and cause; PGT-A in such cases helps concentrate those odds on the embryos most likely to implant.
Frequently Asked Questions
Is PGT mandatory for every IVF cycle in Maharashtra?+
No, PGT is not mandatory for all IVF cycles. It is clinically recommended for specific groups: women over 37, couples with recurrent implantation failure or miscarriages, carriers of hereditary conditions such as thalassaemia, and those with structural chromosomal rearrangements. The HomeIVF Medical Board advises a thorough genetic counselling consultation before deciding, as adding PGT unnecessarily can delay treatment and increase cost without a proportionate clinical benefit.
How long does PGT genetic testing take in India?+
Once trophectoderm cells are biopsied from a Day 5 or Day 6 blastocyst and dispatched to a NABL-accredited genetics laboratory — typically located in Mumbai or Pune for Maharashtra patients — next-generation sequencing analysis results are generally returned within 10 to 14 working days. This means the embryo transfer usually occurs in the cycle following egg retrieval, as a frozen embryo transfer, rather than in the same cycle as the biopsy.
What genetic diseases can PGD detect before embryo transfer?+
PGT-M, commonly called PGD, can detect over 200 single-gene disorders. In Maharashtra, the most clinically relevant conditions screened include beta-thalassaemia, sickle cell disease, spinal muscular atrophy, cystic fibrosis, Duchenne muscular dystrophy, fragile X syndrome, Huntington's disease, and BRCA1/BRCA2 mutations associated with hereditary breast and ovarian cancer. The specific panel must be designed in advance, typically requiring 6-8 weeks of laboratory preparation before the IVF stimulation cycle begins.
Does PGT guarantee a healthy baby or a successful pregnancy?+
PGT significantly reduces — but does not eliminate — the risk of chromosomal abnormalities or inherited single-gene disorders. Euploid embryo transfers still carry a risk of implantation failure and other pregnancy complications unrelated to chromosomal status. IVF success rates in India typically range from 40-55% per cycle depending on age and cause, even with PGT. PGT also does not screen for all possible genetic conditions, so standard prenatal care including second-trimester anomaly scans remains important after a confirmed pregnancy.
Is thalassaemia carrier screening available at home in Maharashtra?+
Yes. HomeIVF's home-visit phlebotomy service, currently available across more than 50 cities and towns in Maharashtra including Mumbai, Pune, Nagpur, and Nashik, allows couples to have blood drawn at home for carrier screening tests such as HPLC (haemoglobin electrophoresis) for thalassaemia. Results are reviewed via teleconsultation with the HomeIVF Medical Board, and if both partners test positive as carriers, a PGT-M planning consultation is initiated promptly without requiring a clinic visit.
How does PGT affect the number of embryos available for transfer?+
PGT reduces the pool of embryos available for transfer because not all embryos will reach the blastocyst stage suitable for biopsy, and of those biopsied, a variable proportion will be reported as aneuploid or affected. In women over 40, it is not unusual for 50-70% of blastocysts to be chromosomally abnormal. This is why the HomeIVF Medical Board sometimes recommends completing two or more retrieval cycles to accumulate sufficient euploid embryos before planning transfer, particularly for patients with low ovarian reserve.
What is the difference between PGT-A and PGT-M and which one do I need?+
PGT-A screens all 24 chromosomes for aneuploidy and is recommended for advanced maternal age, recurrent implantation failure, and unexplained miscarriages. PGT-M targets a specific single-gene disorder known to run in the family — for example, thalassaemia or SMA — and requires a bespoke laboratory probe designed before the IVF cycle. Many couples need only one type; some with both advanced age and a hereditary condition may benefit from combining both. A certified genetic counsellor, accessible via HomeIVF teleconsultation, will advise the most appropriate test for your clinical profile.
How do I start the PGT process with HomeIVF in Maharashtra?+
The first step is booking a free teleconsultation with a HomeIVF specialist, during which your medical history, previous test results, and fertility goals are reviewed. If PGT is appropriate, a home-visit blood draw for carrier screening and hormone baseline tests is scheduled within days. HomeIVF then coordinates genetic counselling, stimulation protocol design, and partnership with a NABL-accredited IVF and genetics laboratory near you in Maharashtra. The entire journey — from first consultation to embryo transfer — is managed through a single care coordinator.
